0001127602-16-048019.txt : 20160401
0001127602-16-048019.hdr.sgml : 20160401
20160401114124
ACCESSION NUMBER: 0001127602-16-048019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160324
FILED AS OF DATE: 20160401
DATE AS OF CHANGE: 20160401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC
CENTRAL INDEX KEY: 0000794172
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 310888197
STATE OF INCORPORATION: OH
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 3471 RIVER HILLS DR
CITY: CINCINNATI
STATE: OH
ZIP: 45244
BUSINESS PHONE: 5132713700
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
FORMER COMPANY:
FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BALDINI LAWRENCE
CENTRAL INDEX KEY: 0001224664
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14902
FILM NUMBER: 161545713
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-03-24
0000794172
MERIDIAN BIOSCIENCE INC
VIVO
0001224664
BALDINI LAWRENCE
3471 RIVER HILLS DRIVE
CINCINNATI
OH
45244
1
EVP, Pres Global Operations
Common Stock
90376
D
Stock Options (Right to Buy)
19.56
2016-03-24
4
A
0
2000
0
A
2026-03-24
Common Stock
2000
2000
D
These options are awarded under the 2012 Stock Incentive Plan in connection with the Company's acquisition of Magellan Diagnostics, Inc. and vest in four equal installments from the date of grant (i.e., 25% per year until fully vested on March 24,
2020).
/s/ Melissa A. Lueke, attorney-in-fact for Lawrence J. Baldini
2016-04-01